United States· US:82448-134_2f197288-544c-45a6-be72-cf723fa15335
Gomekli
A mirdametinib product containing mirdametinib, registered in United States by SpringWorks Therapeutics, Inc.. The same ATC class is registered in 11 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Mirdametinib is registered in 11 of 19 countries.
Countries holding a registration under ATC L01EE05 (mirdametinib), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 9 of them publish a price we can compare per daily dose
Mirdametinib · ATC L01EE05
11 / 19 countries
- Belgiumprice
- Czechiaprice
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Spainprice
- Switzerlandprice
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- MIRDAMETINIB
- Manufacturer
- SpringWorks Therapeutics, Inc.
- Country
- United States (US)
- ATC code
- L01EE05
- ATC class
- Mirdametinib
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- August 9, 2026
Packs & prices · 2
- ndc1182448-134-42
- ndc1182448-134-84
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Mirdametinib in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandEzmekly 1 mg, Tabletten zur Herstellung einer Suspension zum EinnehmenMerck (Schweiz) AG
- SpainEZMEKLY 1 MG COMPRIMIDOS DISPERSABLESMerck Europe B.V.
- FinlandEzmeklyMerck Europe B.V.
- FranceEZMEKLY 1 mg, comprimés dispersiblesMERCK EUROPE (PAYS-BAS)
- BelgiumEzmekly 1 mgMerck Europe
- NetherlandsEzmekly 1 mg dispergeerbare tablettenMerck Europe B.V.
- NorwayEzmeklyMerck Europe B.V.
- PolandEzmeklySpringWorks Therapeutics Ireland Limited
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Ezmekly
- Liechtenstein · Ezmekly
- Norway · Ezmekly
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ab123eab-e077-43c5-abbd-3972fa77e963 GET /v1/drugs/ab123eab-e077-43c5-abbd-3972fa77e963?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "1",
"substance": "MIRDAMETINIB",
"productndc": "82448-134",
"dosage_form": "TABLET, FOR SUSPENSION",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "NDA219379",
"marketing_category": "NDA"
}See everything about mirdametinib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.